John Vavricka - Chief Commercial Officer at Atea Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
AVIR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Vavricka since 05 Jan 2025

Holdings reported by John Vavricka for Atea Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 82,508 $252,474 $3.06 31 Jan 2025 Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
Common Stock 52,081 $159,368 $3.06 31 Jan 2025 Direct
Restricted Stock Units 8,750 $26,775 $3.06 31 Jan 2025 Direct Common Stock
Stock Option (Right to Buy) 132,800 31 Jan 2025 Direct Common Stock

Transactions reported by John Vavricka for Atea Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.